Project Details
| Acronym | NASH |
|---|---|
| Status | Finished |
| Effective start/end date | 8/10/19 → 7/10/24 |
Keywords
- clinical trial
- treatment efficacy
- steatohepatitis
Clinical Trial Phase
- Phase II
A randomized, double-blind, placebo-controlled, multicenter, dose-range, proof-of-concept, 24-week treatment study of IVA337 in adult subjects with nonalcoholic steatohepatitis
- Hodge, Alex (Primary Chief Investigator (PCI))
Project: Research